Lumenis' triLift wins “Best New Dermatology Technology Solution” at the 8th Annual MedTech Breakthrough Awards Program
Prestigious international annual awards program recognizes outstanding digital health and medical technology products and companies
YOKNE AMIRIT, Israel , May 10, 2024 /PRNewswire/ — Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, today announced that TriLift has won the highly competitive “Best New announced the winner of the Product Award.Received the 8th “Dermatology Technology Solution” Awardth Annual MedTech Breakthrough Awards Program.
triLift facial muscle stimulation treatment is a revolutionary advancement in facial aesthetics. Unlike traditional approaches that target only the skin, TriLift offers an innovative approach to addressing facial signs of aging by targeting the underlying muscles. Facial muscles play an important role in determining facial structure, and as we age, facial muscle mass decreases, resulting in a sagging jawline, drooping cheekbones, and wrinkles around the mouth. It may appear or the area under the eyes may decrease.
A true game-changer in the facial aesthetics market, TriLift's deep muscle approach allows providers to go beyond the skin and reach different muscle groups that are important in defining facial structure and overall appearance. Masu. triLift's Dynamic Muscle Stimulation Technology (DMSt™) stimulates muscle contractions to mimic physiological muscle function at higher frequencies and intensities. triLift's DMSt stimulates and tightens facial muscles for a toned and lifted look.
triLift goes beyond the muscle layer to address the skin and volume through the integration of two additional synergistic technologies as part of the treatment. TriPollar® RF regenerates collagen, increases dermal thickness,1 Reduces wrinkles.2 triFX™ high-frequency microneedling with ultra-fine needles also improves smoothness and3 The amount of hyaluronic acid produced is tripled.Four
Recognizing the uniqueness of each facial structure, Tri-Lift has been carefully designed to cater to each individual's different contours, making it the ideal aesthetic solution for all patients and skin types. Short treatment protocol of 20-30 minutesFive triLift has no downtime and offers uncompromising convenience for both patients and providers.
“TriLift results are visibly natural-looking from the first treatment. Dermatologists have been challenged to treat age-related facial structures such as sagging jawlines and drooping cheekbones. “Until now, the only option was to mask the problem without addressing the root cause: facial muscle mass,” said Steve Johansson, Managing Director, MedTech Breakthrough. . “Lumenis has created an entirely new market category with triLift. Its multi-layered approach utilizes three different technologies to address muscle, skin and volume through one comprehensive treatment.”
The mission of the MedTech Breakthrough Awards is to celebrate excellence in the broadest categories of health and medical technology and to recognize innovation, hard work, and success. This year's program attracted thousands of nominations from over 18 countries around the world.
To learn more about this award-winning technology, visit https://trilift.me or click here to find a clinic near you. To stay up to date with triLift, follow Lumenis (@lumenis.aesthetics) on Instagram.
About Lumenis
Lumenis is a global leader in the medical aesthetics market and a world-renowned expert in the development and commercialization of innovative energy-based technologies, including lasers, intense pulsed light (IPL), and radiofrequency (RF). Lumenis is a leader in minimally invasive facial aesthetic products, from skin care to body treatments, with a portfolio of world-renowned technologies.
For more than 50 years, Lumenis' breakthrough products have redefined medicine, set technical and clinical gold standards, revolutionized existing treatments, and created solutions to previously untreatable conditions. I'm here. Lumenis is a portfolio company of his EQT Private Capital Asia. For more information about Lumenis' suite of clinical solutions, please visit www.lumenis.com.
About Trilift
triLift treatment is not suitable for patients with pacemakers, defibrillators, other implanted electronic devices, or metal implants in the treatment area. Risks may include damage to natural skin texture, skin redness, swelling, bruising, itching, and changes in pigmentation. Always consult your treatment provider before choosing this treatment.
For more information about triLift, please visit https://trilift.me/.
About Medtech Breakthrough
The MedTech Breakthrough Awards program is dedicated to recognizing and celebrating excellence and innovation in health and medical technology companies, products and services around the world. Learn more: MedTechBreakthrough.com
contact:
gabby white
+1-219-775-6717
gabby.carlson@lumenis.com
Chen Reingold
+972 548-133-777
Chen.reingold@lumenis.com
[1] Haim Kaplan, Andrea Gat, Clinical and histopathological results after TriPollar™ radiofrequency skin therapy, Journal of Cosmetic and Laser Therapy 2009; 11: 78–84 DOI: 10.1080/14764170902846227
[2] Potekaev N, Zhukova O. Evaluation of the safety and effectiveness of the Maximus system for facial wrinkles. Cosmetics, Dermatology and Applied Journal, 2013. Vol. 3:151-156.
[3] Same as above.
[4] Boinnick S, Blanchet MC. In vitro study of hybrid energy technology using human skin model. Eur J Dermatol 2014; 24(1): 46-52 Oi:10.1684/ejd.2013.2233
[5] We recommend 4-6 weekly treatment courses.
Source Lumenis Be Ltd.
